Important Notice: Owing to calendar schedules imposed by the NIH for the start-up year of this program, applications for 2009-2010 KL2 funding will be due on NOVEMBER 23, 2009. Applicants and their mentors must be prepared to accept KL2 funding for a start date of JANUARY, 2010. Please contact, Ms. Kathryn Nyland, Program Administrator (Kathryn.Nyland@va.gov), if you have questions.
ABOUT THE PROGRAM
The KL2 program in Translational Research is a new, University-wide, post-doctoral training and career development opportunity for physicians, nurses, dentists, and other appropriate health professionals. This program is most appropriate for individuals in post-doctoral training who are on the path to, but have not yet achieved research independence, and who will continue to develop as investigators under the guidance of an established mentor. The program is a component of the Translational Research Education and Careers (TREC) unit of New York University’s NIH-funded Clinical Translational Science Institute (CTSI). Applicants to the program must be participating in full-time research and career development at NYU.
The program includes formal didactic work and mentored research
experience. At the completion of the program graduates will
have the skills and track record to successfully obtain ongoing
research funding. Program success depends
on the mentor(s) providing the resources necessary for the trainee to conduct
the proposed research, including access to clinical populations and to existing
data bases, and support in study design and coordination. Where possible,
however, the program will provide advice and/or assistance in obtaining additional
access to such resources, and will strive to link trainees with additional
collaborators/resources in schools beyond their own. Individually-tailored
training in biological and molecular sciences, social and behavioral sciences,
clinically-relevant research methods, and statistics, will be available as
needed for the individual’s long-term goals.
In addition to providing support and resources for individual
trainees, the KL2 program will have as secondary goals the encouragement
of interaction and cross-pollination between trainees with varying translational
research interests, and the promotion of community building within the
interest area of translational research. To this end, and to contribute to trainees’ research
and career development, KL2 scholars will participate in
a KL2 translational journal club, and research-in-progress conferences,
to be overseen by the KL2 Directors. In addition, KL2 scholars will also
participate in common activities with other trainees within the TREC
program, for example monthly TREC Grand Rounds.
This new program will be administered through the TREC and
Co-directed by Francisco Xavier Castellanos (MD, NYU School of Medicine/NYU
Child Study Center), Ralph V. Katz (DMD, MPH, PhD, NYU College of Dentistry),
and Christine Kovner (RN, PhD, FAAN, NYU College of Nursing).
PROGRAM ELEMENTS
Support
The KL2 Translational Research Scholars Program provides
a minimum of two years of consecutive funding for each Scholar,
consisting of consecutive 12-month appointments. Additional
year(s) of funding may be made available in the future dependent
upon the availability of funds and the accomplishments/needs
of Scholars. KL2 Scholars are expected to pursue other grants/funding
sources for subsequent career development (i.e., once the
KL2 is complete) based on the KL2 period of protected time.
The NYU KL2 program is committed to supporting a minimum
of two Scholars per year throughout the five year period
of the NYU CTSI; subsequent program continuation will depend
on NIH renewal of the NYU CTSI. Funding includes a stipend
providing up to 75% institutional base salary, as well as
funds for project-related expenses (including tuition for
required courses), and travel budget.
Coursework
Required didactics—All KL2 Scholars will be
required to complete, or to have completed: 1) a course in
Grant Writing, 2) the required Human Subjects Medical School
online tutorial course, and 3) a course in Scientific Integrity
and Responsible Conduct of Clinical Research, all offered
at NYU.
Additional coursework—In addition to the required
courses above, all KL2 Scholars will be required to
select at least 8 credit hours or their
equivalent from available course offerings at NYU,
e.g., the School of Medicine, College of Dentistry, College
of Nursing, MPH in Global Health program, which may be accessed
at www.nyu.edu. While specific
courses are not required, it is expected that the courses
taken will enhance the research activities of the individual
student; consequently the selection of specific courses must
be done in consultation with the trainee’s primary
mentor and will be subject to approval by the KL2 Directors.
With special permission, relevant courses at other institutions
may be considered, within the budgetary constraints of the
program. Scholars are also encouraged
to consider enrolling in appropriate degree programs at NYU
(e.g., the TREC K30 Masters of Science in Clinical Investigation
program, which is designed to inter-digitate with trainees’ ongoing
research activities—see the Masters program page under
the TREC website).
Mentored Research Project and Mentoring
The
most critical component of this program is the opportunity for
Scholars to apply what they are learning in a mentored research
project. Each Scholar will be mentored at multiple
levels. They will work most closely with a primary research
mentor who will supervise the development and implementation
of the study. In regular meetings, they will plan the design,
and troubleshoot the progress, of the project. Identification
of one or more interdisciplinary supplementary mentors, who
can provide project skills and/or resources not otherwise available,
will be strongly encouraged through the CTSI Transdisciplinary
Mentoring Program.
Each trainee and his or her mentor(s) will also meet twice
per year with the program executive committee. Prior
to this meeting, the committee will obtain an update of the
trainee’s progress from the primary research mentor.
The goals of these periodic meetings are to establish and review
individual learning goals, plan choice of elective courses,
review research progress, and troubleshoot programmatic and/or
research roadblocks that may keep a Scholar from meeting his/her
goals. Scholars will also benefit from peer mentoring as described
under KL2 Cohort Activities, below.
KL2 Cohort Activities
All KL2 Scholars will meet, quarterly, for a KL2 Works-in-Progress
session, at which KL2 Scholars will present, on a rotating
basis, their interim research accomplishments and the challenges
they encounter. Trainees will benefit from the focused feedback
of their peers as well as the KL2 Directors, and develop
their own skills at critical review and constructive feedback
of research protocols. These sessions will also give Scholars
an opportunity to learn of research in other areas, socialize,
broaden horizons and teach one another. In addition to the
KL2 Works-in-Progress session, KL2 Scholars will meet jointly
with trainees in the other TREC programs (K30 trainees, TL1
trainees, Physician Scientist Training Program participants)
and their mentors for a monthly CTSI Grand Rounds. KL2
Scholars will also have access to other common TREC activities
as these are developed.
Eligibility and Application Process
KL2 Scholars will be selected from among postdoctoral health
professionals conducting translational research at NYU. To
be eligible, the applicant will have successfully completed
the equivalent of at least one year of postdoctoral research,
and be working in a field that can be informed by translational
approaches to health and healthcare, at the time of application. At
the time of application, trainees must be active participants
in a relevant on-going investigation and have the support of
their proposed mentor and Chair or Dean. As appropriate to
their training/activities, it is anticipated that candidates
will typically have completed clinical training and will be
either licensed to practice in New York State or have a doctoral
degree in a health profession or the equivalent. An applicant
must be a U.S. Citizen, permanent resident, or otherwise meet
the requirements of the NIH under this funding mechanism.
A call for applications will be issued in the fall of each cycle to NYU faculty and Deans to seek applicants for the KL2 position(s). Applicants will submit a set of documents including a CV, set of personal statements and letters of support.
The KL2 Scholars will be selected by KL2 Program Directors, consisting of Drs. Kovner, Katz and Castellanos, in consultation with the TREC Executive Committee, based on (a) past accomplishments in their respective research field; (b) the research proposal; (c) potential to contribute to translational research in health sciences; (d) the committee’s assessment of the extent to which a KL2 award is likely to further the Scholar’s career development and lead to future independence as an investigator. In selecting awardees, the committee will also take into account the goal of establishing a diverse, multi-disciplinary cohort of KL2 Scholars over the years. In considering applications, the committee will reserve the option of requesting additional information, and of requesting interviews with finalists.
Important Notice: Applications for 2009-2010 KL2 funding will be due by November 23, 2009. Applicants must be prepared to accept KL2 funding for a start date of January, 2010.